PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27499787-0	2016	Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ.	Gliclazide	76-86	ATP binding cassette subfamily B member 1	Homo sapiens	14-28	
27499787-5	2016	This study investigated the effects of gliclazide, metformin, and pioglitazone on the function and expression of P-gp.	Gliclazide	39-49	ATP binding cassette subfamily B member 1	Homo sapiens	113-117	
27499787-11	2016	P-gp expression was decreased by gliclazide, metformin and pioglitazone.	Gliclazide	33-43	ATP binding cassette subfamily B member 1	Homo sapiens	0-4	
27499787-13	2016	It was found that gliclazide, metformin, and pioglitazone inhibited P-gp efflux activity in situ and down-regulated P-gp expression in vitro.	Gliclazide	18-28	ATP binding cassette subfamily B member 1	Homo sapiens	68-72	
27499787-13	2016	It was found that gliclazide, metformin, and pioglitazone inhibited P-gp efflux activity in situ and down-regulated P-gp expression in vitro.	Gliclazide	18-28	ATP binding cassette subfamily B member 1	Homo sapiens	116-120